2017– 2018 has been a period marked by significant ups and downs in the pharma and healthcare industries. From marking the end of the Hepatitis-C treatment era, which was a significant contributor to the industry’s growth rate from 2014– 2016, to the greater impact of expiring patents and the introduction of Biosimilars, the year has […]